Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ucb S.A. (UCBJF)

Ucb S.A. (UCBJF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ucb S.A. Allee de la Recherche 60 Brussels C9 1070 BEL

www.ucb.com P: 32-2559-9999

Description:

UCB SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in providing therapy for central nervous system disorders, including epilepsy, diabetic neuropathic pain, sclerosis and Parkinson's disease. It also provides therapy in the areas of oncology, immunology, inflammation, allergy and respiratory diseases. UCB delivers small and large molecule solutions to specialists for use in the treatment of severe diseases.

Key Statistics

Overview:

Market Capitalization, $K 25,268,192
Enterprise Value, $K 27,376,442
Shares Outstanding, K 189,020
Annual Sales, $ 5,267 M
Annual Net Income, $ 371,200 K
EBIT, $ 0 K
EBITDA, $ 1,332 M
60-Month Beta 0.56
% of Institutional Shareholders 0.00%
Float, K 189,020
% Float 100.00%
Short Volume Ratio 0.83

Growth:

1-Year Return 38.89%
3-Year Return 64.87%
5-Year Return 0.00%
5-Year Revenue Growth -3.72%
5-Year Earnings Growth -18.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/22/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payable Date 05/05/14
Dividend Payout Ratio 0.00%

UCBJF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 29.67
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 7.05%
Debt/Equity 0.32
Price/Sales N/A
Price/Cash Flow 16.91
Price/Book 2.65
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar